Comparing New-onset Diabetes in Post Moderate-to-severe Coronavirus Disease 2019 Patients with Newly Diagnosed Diabetes Patients with Mild or without Prior Coronavirus Disease 2019 Infection

Background: Systemic inflammation and various drugs used for treating coronavirus disease 2019 (COVID-19) including high-dose corticosteroids play a role in the development of new-onset diabetes (NOD). Patients of all ages and genders recovering from COVID-19 reportedly have an increased incidence a...

Full description

Bibliographic Details

Published in:	APIK Journal of Internal Medicine
Main Authors:	Rupak Chatterjee, Shatavisa Mukherjee, Supratik Bhattacharyya, Debasis Basu, Netai Pramanik
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-09-01
Subjects:	coronavirus disease 2019 insulin resistance new-onset diabetes
Online Access:	https://journals.lww.com/10.4103/ajim.ajim_94_23